Beneficial ownership — 13D / 13G
87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| EMINENCE CAPITAL, LP | GTBIF Green Thumb Industries Inc. | 13G/A | 3.6% | Mar 31, 2026 | 6mo |
| VAN ECK ASSOCIATES CORP | UUUU Energy Fuels Inc | 13G/A | 6.48% | Mar 31, 2026 | 6mo |
| CastleKnight Master Fund LP | CYH Community Health Systems Inc | 13G/A | 9% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | AUTL Autolus Therapeutics plc | 13G/A | 5.94% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | CVLG Covenant Logistics Group, Inc. | 13G | 5.2% | Mar 31, 2026 | 6mo |
| Fort Baker Capital Management LP | FTW PRESIDIO PRODUCTION Co | 13G/A | 2.8% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | TMCI Treace Medical Concepts, Inc. | 13G/A | 9.85% | Mar 31, 2026 | 6mo |
| Nextech Crossover I GP S.a. r.l. | TNGX Tango Therapeutics, Inc. | 13G/A | 5.1% | Mar 31, 2026 | 6mo |
| BAKER BROS. ADVISORS LP | KALA KALA BIO, Inc. | 13G/A | 0.01% | Mar 31, 2026 | 6mo |
| Kerry Propper | CAPN Cayson Acquisition Corp | 13G/A | 0% | Mar 31, 2026 | 6mo |
| Encompass Capital Advisors LLC | SEI Solaris Energy Infrastructure, Inc. | 13G/A | 3.01% | Mar 31, 2026 | 6mo |
| CITADEL ADVISORS LLC | SPRB Spruce Biosciences, Inc. | 13G/A | 5.1% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | CRAQ Cal Redwood Acquisition Corp. | 13G/A | 9.58% | Mar 31, 2026 | 6mo |
| BAKER BROS. ADVISORS LP | GLUE Monte Rosa Therapeutics, Inc. | 13G/A | 9.99% | Mar 31, 2026 | 6mo |
| Graham Holdings Co | PUBM PubMatic, Inc. | 13G/A | 8.9% | Mar 31, 2026 | 6mo |
| Point72 Asset Management, L.P. | EDSA Edesa Biotech, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| Alyeska Investment Group, L.P. | BBCQ Bleichroeder Acquisition Corp. II | 13G | 5.54% | Mar 31, 2026 | 6mo |
| Kenneth Griffin | MED Medifast Inc | 13G | 6.5% | Mar 31, 2026 | 6mo |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | ELMES Elme Communities | 13G/A | 8.4% | Mar 31, 2026 | 6mo |
| RTW INVESTMENTS, LP | RAPT RAPT Therapeutics, Inc. Common Stock | 13G/A | 0% | Mar 31, 2026 | 6mo |
| CANNELL CAPITAL LLC | GLXZ Galaxy Gaming, Inc. | 13G | 5.2% | Mar 31, 2026 | 6mo |
| Caligan Partners LP | IRD Opus Genetics, Inc. | 13G | 8.5% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | ASTI Ascent Solar Technologies, Inc. | 13G/A | 4.99% | Mar 31, 2026 | 6mo |
| Anson Funds Management LP | MCGA Yorkville Acquisition Corp. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| LAZARD ASSET MANAGEMENT LLC | IIF Morgan Stanley India Investment Fund, Inc. | 13G | 6.5% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | IDA Idacorp Inc | 13G/A | 5.2% | Mar 31, 2026 | 6mo |
| Orbis Investment Management Limited | CRSP CRISPR Therapeutics AG | 13G/A | 6.3% | Mar 31, 2026 | 6mo |
| COHEN & STEERS, INC. | KIM Kimco Realty Corp | 13G/A | 7.93% | Mar 31, 2026 | 6mo |
| COHEN & STEERS, INC. | NTST NETSTREIT Corp. | 13G/A | 14% | Mar 31, 2026 | 6mo |
| Qube Research & Technologies Ltd | SLMT Solmate Infrastructure PLC | 13G/A | 3.6% | Mar 31, 2026 | 6mo |
| Two Seas Capital LP | MDRX Veradigm Inc. Common Stock | 13G/A | 8.2% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | MANH Manhattan Associates Inc | 13G | 5.9% | Mar 31, 2026 | 6mo |
| PAULSON & CO. INC. | MDGL Madrigal Pharmaceuticals, Inc. | 13G/A | 6.1% | Mar 31, 2026 | 6mo |
| EVENTIDE ASSET MANAGEMENT, LLC | COLL Collegium Pharmaceutical, Inc | 13G/A | 4.5% | Mar 31, 2026 | 6mo |
| TORONTO DOMINION BANK | IMTX Immatics N.V. | 13G | 5.5% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | SARO StandardAero, Inc. | 13G/A | 11.7% | Mar 31, 2026 | 6mo |
| PERCEPTIVE ADVISORS LLC | TRAW Traws Pharma, Inc. | 13G/A | 6.1% | Mar 31, 2026 | 6mo |
| Vestal Point Capital, LP | APRE Aprea Therapeutics, Inc. | 13G | 9.9% | Mar 31, 2026 | 6mo |
| Point72 Asset Management, L.P. | PTN Palatin Technologies Inc | 13G/A | 0.5% | Mar 31, 2026 | 6mo |
| EARNEST PARTNERS LLC | GATX Gatx Corp | 13G/A | 7.3% | Mar 31, 2026 | 6mo |
| CITADEL ADVISORS LLC | ASST Strive, Inc. | 13G/A | 5.2% | Mar 31, 2026 | 6mo |
| Soroban Capital Partners LP | DPZ Dominos Pizza Inc | 13G | 7.4% | Mar 31, 2026 | 6mo |
| Lawrence M. Blatt, Ph.D. | ALGS Aligos Therapeutics, Inc. | 13G | 5.1% | Mar 31, 2026 | 6mo |
| SB INVESTMENT ADVISERS (UK) LTD | NRGV Energy Vault Holdings, Inc. | 13G/A | 8.9% | Mar 31, 2026 | 6mo |
| Rubric Capital Management LP | CVGW Calavo Growers Inc | 13G | 7.93% | Mar 31, 2026 | 6mo |
| Khrom Investments Fund, LP | ACHC Acadia Healthcare Company, Inc. | 13G/A | 5.66% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | RUSHA Rush Enterprises Inc Tx | 13G/A | 4% | Mar 31, 2026 | 6mo |
| Point72 Asset Management, L.P. | DSGN Design Therapeutics, Inc. | 13G/A | 4.4% | Mar 31, 2026 | 6mo |
| Anson Funds Management LP | NRXP NRX Pharmaceuticals, Inc. | 13G/A | 4.9% | Mar 31, 2026 | 6mo |
| CITADEL ADVISORS LLC | DPRO Draganfly Inc. | 13G/A | 5.3% | Mar 31, 2026 | 6mo |